<DOC>
	<DOCNO>NCT01329887</DOCNO>
	<brief_summary>This study evaluation effect ketanserine sublingual microcirculation intensive care patient severe sepsis .</brief_summary>
	<brief_title>The Effect Ketanserin Microcirculation Sepsis</brief_title>
	<detailed_description>This pilot study , include 10 ICU patient severe sepsis MFI &lt; 2,5 fulfillment strict resuscitation protocol . At start study , baseline SDF measurement make , MFI &lt; 2,5 inclusion study permit intravenous ketanserin administration start subsequently increase , guided effect sublingual MFI , safe maximum dosage reach . Safety margin hypotension define study protocol .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Ketanserin</mesh_term>
	<criteria>severe sepsis MFI &lt; 2,5 resuscitation age &lt; 18 year old pregnant participation trial prolong Qt interval</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>microcirculation</keyword>
	<keyword>SDF</keyword>
	<keyword>ketanserin</keyword>
	<keyword>severe sepsis</keyword>
</DOC>